These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7583341)

  • 1. Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells.
    Chen Y; Peng L; Zhang X; Stolzenburg JU; Hertz L
    Brain Res Bull; 1995; 38(2):153-9. PubMed ID: 7583341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration.
    Kong EK; Peng L; Chen Y; Yu AC; Hertz L
    Neurochem Res; 2002 Feb; 27(1-2):113-20. PubMed ID: 11930908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
    Pälvimäki EP; Roth BL; Majasuo H; Laakso A; Kuoppamäki M; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 1996 Aug; 126(3):234-40. PubMed ID: 8876023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.
    Lucchelli A; Santagostino-Barbone MG; Barbieri A; Candura SM; Tonini M
    Br J Pharmacol; 1995 Mar; 114(5):1017-25. PubMed ID: 7780635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of glycogenolysis in astrocytes by fluoxetine, an antidepressant acting like 5-HT.
    Zhang X; Peng L; Chen Y; Hertz L
    Neuroreport; 1993 Sep; 4(11):1235-8. PubMed ID: 7693014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.
    Baudry A; Mouillet-Richard S; Schneider B; Launay JM; Kellermann O
    Science; 2010 Sep; 329(5998):1537-41. PubMed ID: 20847275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac).
    Ni YG; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2036-40. PubMed ID: 9050900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
    Sarkar A; Chachra P; Vaidya VA
    Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
    Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
    Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.
    Lee HJ; Rao JS; Ertley RN; Chang L; Rapoport SI; Bazinet RP
    Psychopharmacology (Berl); 2007 Jan; 190(1):103-15. PubMed ID: 17093977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues.
    Magyar J; Rusznák Z; Harasztosi C; Körtvély A; Pacher P; Bányász T; Pankucsi C; Kovács L; Szûcs G; Nánási PP; Kecskeméti V
    Int J Mol Med; 2003 Apr; 11(4):535-42. PubMed ID: 12632110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 5-HT
    Colmenares-Aguilar M; Lima L
    Adv Exp Med Biol; 2017; 975 Pt 2():1129-1140. PubMed ID: 28849528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
    Marek GJ; Martin-Ruiz R; Abo A; Artigas F
    Neuropsychopharmacology; 2005 Dec; 30(12):2205-15. PubMed ID: 15886717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing.
    Englander MT; Dulawa SC; Bhansali P; Schmauss C
    J Neurosci; 2005 Jan; 25(3):648-51. PubMed ID: 15659601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
    Millan MJ; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
    Pilar-Cuéllar F; Vidal R; Pazos A
    Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-depressant effects of phthalazinone-based triple-acting small molecules against 5-HT
    Kim J; Cha E; Park WK; Lee HY; Lim SM; Kim HJ; Pae AN
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126882. PubMed ID: 31889666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.